Anemia and Duration of Mechanical Ventilation

May 2, 2026 updated by: Annop Piriyapatsom, MD, Mahidol University

The Correlation Between Period of Anemia and Duration of Mechanical Ventilation in Patients Admitted to the Surgical Intensive Care Unit

In mechanically ventilated patients in intensive care unit, anemia is commonly seen and it is probably associated with adverse outcomes including mortality. We aim to investigate the impact of duration of anemia and the duration of mechanical ventilation as well as clinical outcomes in critically ill patients in intensive care unit who required ventilatory support >96 hr.

Study Overview

Detailed Description

Anemia is one of the most common conditions encountered critically ill patients. Various mechanisms can put these patients at risk of anemia including gastrointestinal hemorrhage, iron deficiency, inflammation and infection, stress, and multiple blood testing. Anemia can affect cardiopulmonary function as depletion in oxygen content in body. In mechanically ventilated patients, anemia is associated with increased duration of mechanical ventilation, increased length of stay, and possibly increased mortality. Some research suggested that hemoglobin level <8.5 g/dl was a potential risk factor for adverse outcome in critically ill patients required mechanical ventilation >96 hr. However, most researches focused on hemoglobin levels and the associated adverse events in mechanically ventilated patients. To the best of our knowledge, there are few studies reported the impact of the duration of anemia and the clinical outcomes in these patients. We hypothesize that the short duration of anemia developed in mechanically ventilated patients has no effect on duration of mechanical ventilation. We, therefore, aim to investigate the impact of the duration of anemia on duration of mechanical ventilation in critically ill patients required ventilatory support >96 hours.

Study Type

Observational

Enrollment (Actual)

236

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bangkok
      • Bangkok Noi, Bangkok, Thailand, 10700
        • Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients admitted to the surgical intensive care unit and required ventilatory support with invasive mechanical ventilation for more than 96 hours

Description

Inclusion Criteria:

  • Patients whose age of equal or more than 18 years old
  • Patients admitted to the surgical intensive care unit during the study period
  • Patients required ventilatory support with invasive mechanical ventilation for more than 96 hours

Exclusion Criteria:

  • Patients whose data regarding time of beginning or ending of ventilatory support missed
  • Patients who are previously included in this study and are re-admitted

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of mechanical ventilation
Time Frame: 28 days after initiation of ventilatory support
Days patients received mechanical ventilation
28 days after initiation of ventilatory support

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of anemia
Time Frame: 28 days after initiation of ventilatory support
Days patients had hemoglobin level <8 g/dl while they were on ventilatory support
28 days after initiation of ventilatory support
Cardiovascular dysfunction
Time Frame: 28 days after initiation of ventilatory support
SOFA cardiovascular component equal to 1, 3, or 4
28 days after initiation of ventilatory support
Respiratory dysfunction
Time Frame: 28 days after initiation of ventilatory support
SOFA respiratory component >1
28 days after initiation of ventilatory support
Renal dysfunction
Time Frame: 28 days after initiation of ventilatory support
SOFA respiratory component >1
28 days after initiation of ventilatory support
Gastrointestinal dysfunction
Time Frame: 28 days after initiation of ventilatory support
SOFA gastrointestinal component >1
28 days after initiation of ventilatory support
Hematologic dysfunction
Time Frame: 28 days after initiation of ventilatory support
SOFA hematologic component >1
28 days after initiation of ventilatory support
ICU length of stay
Time Frame: Up to 90 days following inclusion
Duration from ICU admission to ICU discharge
Up to 90 days following inclusion
Hospital length of stay
Time Frame: Up to 90 days following inclusion
Duration from hospital admission to hospital discharge
Up to 90 days following inclusion
ICU mortality
Time Frame: Up to 90 days following inclusion
Status at ICU discharge either alive or deceased
Up to 90 days following inclusion
Hospital mortality
Time Frame: Up to 90 days following inclusion
Status at hospital discharge either alive or deceased
Up to 90 days following inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Annop Piriyapatsom, MD, Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 8, 2022

Primary Completion (Actual)

October 31, 2023

Study Completion (Actual)

April 30, 2024

Study Registration Dates

First Submitted

May 16, 2022

First Submitted That Met QC Criteria

May 16, 2022

First Posted (Actual)

May 19, 2022

Study Record Updates

Last Update Posted (Actual)

May 5, 2026

Last Update Submitted That Met QC Criteria

May 2, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anemia

Subscribe